【药物名称】HS-378
化学结构式(Chemical Structure):
参考文献No.28387
标题:New antagonist cpds.
作者:Schmidhammer, H. (AstraZeneca plc)
来源:EP 0759922; JP 1998500131; US 6136817; WO 9531463
合成路线图解说明:

The title indolomorphinan derivative was synthesized by Fisher indole synthesis from the known 14-O-ethyl-5-methylnaltrexone (I) and phenylhydrazine hydrochloride (II) in refluxing acetic acid, followed by conversion to the corresponding hydrochloride salt.

参考文献No.586203
标题:Synthesis and biological evaluation of 14-alkoxymorphinans. 14. 14-Ethoxy-5-methyl substituted indolomorphinans with delta opioid receptor selectivity
作者:Monory, K.; Daurer, D.; Schmidhammer, H.; Borsodi, A.; Wieser, M.; Traynor, J.R.; Elliott, J.
来源:Bioorg Med Chem Lett 1997,7(2),151
合成路线图解说明:

The title indolomorphinan derivative was synthesized by Fisher indole synthesis from the known 14-O-ethyl-5-methylnaltrexone (I) and phenylhydrazine hydrochloride (II) in refluxing acetic acid, followed by conversion to the corresponding hydrochloride salt.

参考文献No.586205
标题:A novel method for the introduction of a 5-beta-methyl group into 4,5-alpha-epoxymorphinan-6-ones via the enol ether
作者:Krassing, R.; et al.
来源:Helv Chim Acta 2000,83(2),380
合成路线图解说明:

A further procedure for the preparation of (I) from naltrexone (III) has been reported. Naltrexone (III) was O-alkylated with diethyl sulfate in the presence of NaH to give (IV). Deprotonation of (IV) using the combination potassium tert-butoxide/butyllithium, followed by methylation with dimethyl sulfate, yielded the 5-methyl derivative (V). The aryl- and enol ether groups of (V) were then cleaved by means of concentrated HBr.

参考文献No.803859
标题:
作者:
来源:Helv Chim Acta 1993,76476
合成路线图解说明:

The title indolomorphinan derivative was synthesized by Fisher indole synthesis from the known 14-O-ethyl-5-methylnaltrexone (I) and phenylhydrazine hydrochloride (II) in refluxing acetic acid, followed by conversion to the corresponding hydrochloride salt.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us